Clinical Trial Update: Concurrent Chemoradiotherapy Combined With Immunotherapy in Patients With Potentially Resectable Pancreatic Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating concurrent chemoradiotherapy with immunotherapy in potentially resectable pancreatic cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Snippet

Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | Conditions: Pancreatic Carcinoma | Phase 2 | Status: UNKNOWN